These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2983267)

  • 1. Blockade of intrathecal 5-hydroxytryptamine-induced antinociception in rats by noradrenaline depletion.
    Minor BG; Post C; Archer T
    Neurosci Lett; 1985 Feb; 54(1):39-44. PubMed ID: 2983267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete blockade and attenuation of 5-hydroxytryptamine induced analgesia following NA depletion in rats and mice.
    Archer T; Arweström E; Jonsson G; Minor BG; Post C
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):255-61. PubMed ID: 3841256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.
    Archer T; Minor BG; Post C
    Brain Res; 1985 Apr; 333(1):55-61. PubMed ID: 3158373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic-serotonergic interactions and nociception in the rat.
    Archer T; Jonsson G; Minor BG; Post C
    Eur J Pharmacol; 1986 Jan; 120(3):295-307. PubMed ID: 3081358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine.
    Danysz W; Jonsson G; Minor BG; Post C; Archer T
    Behav Neural Biol; 1986 Jul; 46(1):71-86. PubMed ID: 3015120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic and purinergic involvement in spinal antinociception by 5-hydroxytryptamine and 2-methyl-5-hydroxytryptamine.
    Sawynok J; Reid A
    Eur J Pharmacol; 1991 Nov; 204(3):301-9. PubMed ID: 1663459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine.
    Minor BG; Persson ML; Post C; Jonsson G; Archer T
    J Neural Transm; 1988; 72(2):107-20. PubMed ID: 3133452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.
    Minor BG; Archer T; Post C; Jonsson G; Mohammed AK
    J Neural Transm; 1986; 66(3-4):243-59. PubMed ID: 3097248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia.
    Zhong FX; Ji XQ; Tsou K
    Eur J Pharmacol; 1985 Oct; 116(3):327-30. PubMed ID: 2866969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests.
    Kuraishi Y; Hirota N; Satoh M; Takagi H
    Brain Res; 1985 Feb; 326(1):168-71. PubMed ID: 3838258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.
    Sawynok J; Reid A
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):1-8. PubMed ID: 2402297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesia induced by 5-hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-depletion in rats.
    Post C; Minor BG; Davies M; Archer T
    Brain Res; 1986 Jan; 363(1):18-27. PubMed ID: 3484988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine mediates calcium-induced antinociception and potentiation of noradrenergic antinociception in the spinal cord.
    Sawynok J; Reid A; Isbrucker R
    Brain Res; 1990 Aug; 524(2):187-95. PubMed ID: 2127235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the antinociception induced by intrathecally administered carbachol.
    Gillberg PG; Gordh T; Hartvig P; Jansson I; Pettersson J; Post C
    Pharmacol Toxicol; 1989 Apr; 64(4):340-3. PubMed ID: 2748539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion.
    Post C; Persson ML; Archer T; Minor BG; Danysz W; Sundström E
    Eur J Pharmacol; 1987 May; 137(1):107-16. PubMed ID: 2886347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenaline depletion increases noradrenaline-induced antinociception in mice.
    Post C; Arweström E; Minor BG; Wikberg JE; Jonsson G; Archer T
    Neurosci Lett; 1985 Aug; 59(1):105-9. PubMed ID: 2413400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between serotonin and substance P in the spinal regulation of nociception.
    Eide PK; Hole K
    Brain Res; 1991 Jun; 550(2):225-30. PubMed ID: 1715803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.
    Sawynok J; Reid A; Nance D
    J Pharmacol Exp Ther; 1991 Jul; 258(1):370-80. PubMed ID: 1906540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-monoamine interactions in spinal antinociception: evidence for serotonin but not norepinephrine reciprocity.
    Kellstein DE; Malseed RT; Goldstein FJ
    Pain; 1988 Jul; 34(1):85-92. PubMed ID: 2841636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors.
    Tamano R; Ishida M; Asaki T; Hasegawa M; Shinohara S
    Neurosci Lett; 2016 Feb; 615():78-82. PubMed ID: 26806036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.